Showing results (211-220 of 377) with videos related to
Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutationsMiriam J Smith, Christian Beetz, Simon G Williams, et al.Journal of Medical Genetics|July 21, 2009
Breast cancer susceptibility variants alter risks in familial diseaseAyse Latif, Kristen D Hadfield, Stephen A Roberts, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancerLouise M Byrd, Andrew Shenton, Eamonn R Maher, et al.Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.Cell Cycle (Georgetown, Tex.)|December 22, 2012
Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metforminRosa Sanchez-Alvarez, Ubaldo E Martinez-Outschoorn, Rebecca Lamb, et al.Breast Cancer Research : BCR|March 29, 2008
Evaluation of the current knowledge limitations in breast cancer research: a gap analysisAlastair Thompson, Keith Brennan, Angela Cox, et al.Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.Cell Cycle (Georgetown, Tex.)|October 29, 2011
Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cellsUbaldo E Martinez-Outschoorn, Richard G Pestell, Anthony Howell, et al.British Journal of Cancer|July 31, 2025
Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancerMichelle Harvie, Mary Pegington, Anthony Howell, et al.Breast Cancer Research and Treatment|July 13, 2016
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trialsAdam R Brentnall, Jack Cuzick, Helen Byers, et al.Pageof 38